25th Sep 2017 9:46 am |
RNS |
Cantor Fitzgerald Healthcare Conference 2017 |
22nd Sep 2017 12:36 pm |
RNS |
Director Dealings |
20th Sep 2017 3:25 pm |
RNS |
Holding(s) in Company |
19th Sep 2017 8:58 am |
RNS |
Director Dealings |
15th Sep 2017 9:21 am |
RNS |
Director/PDMR Shareholding |
12th Sep 2017 7:15 am |
RNS |
Hardman Research: New advanced therapies era |
7th Sep 2017 10:11 am |
RNS |
Holdings in Company |
5th Sep 2017 11:45 am |
RNS |
Director/PDMR Shareholding |
5th Sep 2017 11:39 am |
RNS |
Director/PDMR Shareholding |
5th Sep 2017 7:00 am |
RNS |
OXB to Present at Rodman & Renshaw Conference |
1st Sep 2017 9:25 am |
RNS |
Total Voting Rights |
30th Aug 2017 4:34 pm |
RNS |
CTL019 receives FDA approval |
29th Aug 2017 7:00 am |
RNS |
Stuart Paynter starts as new CFO |
24th Aug 2017 10:41 am |
RNS |
Hardman Research: Ready for CTL019 approval |
23rd Aug 2017 10:31 am |
RNS |
Director Dealings / Market Share Purchase |
22nd Aug 2017 10:35 am |
RNS |
Director Dealings / Market Share Sale and Purchase |
17th Aug 2017 7:00 am |
RNS |
Interim Results |
11th Aug 2017 7:00 am |
RNS |
OXB announces Innovate UK £2m collaboration |
7th Aug 2017 9:05 am |
RNS |
Holding(s) in Company |
7th Aug 2017 7:00 am |
RNS |
MHRA Licence For Commercial Supply |
1st Aug 2017 9:19 am |
RNS |
Total Voting Rights |
25th Jul 2017 7:00 am |
RNS |
Notice of Interim Results |
24th Jul 2017 10:10 am |
RNS |
Director Dealings / Market Share Purchase |
18th Jul 2017 8:47 am |
RNS |
Director Dealings / Market Share Sale and Purchase |
14th Jul 2017 4:49 pm |
RNS |
Director/PDMR Shareholding |
14th Jul 2017 3:30 pm |
RNS |
PDMR Shareholding |
14th Jul 2017 11:41 am |
RNS |
LTIP for Long Term Incentive Plan |
13th Jul 2017 12:38 pm |
RNS |
Director Dealings / Market Share Sale and Purchase |
13th Jul 2017 7:15 am |
RNS |
Holdings in Company |
13th Jul 2017 7:00 am |
RNS |
FDA AdCom Recommends CTL019 for Approval |
11th Jul 2017 9:29 am |
RNS |
Director Dealings / Market Share Sale and Purchase |
7th Jul 2017 10:15 am |
RNS |
Hardman Research: Major deal to supply Novartis |
6th Jul 2017 7:15 am |
RNS |
Holding(s) in Company |
6th Jul 2017 7:00 am |
RNS |
Major Commercial and Clinical Supply Agreement |
3rd Jul 2017 2:20 pm |
RNS |
Total Voting Rights |
3rd Jul 2017 2:18 pm |
RNS |
Block Listing |
30th Jun 2017 10:38 am |
RNS |
Refinancing of Debt Facility |
23rd Jun 2017 10:12 am |
RNS |
Director Dealings / Market Share Purchase |
14th Jun 2017 3:00 pm |
RNS |
Findings from Phase II JULIET Study |
7th Jun 2017 7:00 am |
RNS |
OXB notes FDA Advisory Committee to review CTL019 |